Skip to main content

Fortress Biotech, Inc.

FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001429260

No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.

Other share classesFBIOP

Q3 2024 vs. Q2 2024

How the institutions holding Fortress Biotech, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of FBIO: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders50150+1
Shares3.62M110.0K4.45M+932.8K (+26.5%)
Value$6.21M$188.0K$6.43M+$401.3K (+6.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Fortress Biotech, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to FBIO in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.111,028$160.4K0.00%
Renaissance Technologies LLC78,088$112.8K0.00%
HB Wealth Management, LLC55,333$80.0K0.00%
Citigroup Inc12,917$18.7K0.00%
Federated Hermes, Inc.263$3800.00%
Danske Bank A/S3$40.00%

Sold out (5)

Institutions that held Fortress Biotech, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of FBIO in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
National Asset Management, Inc.120,814$206.6K
MYDA Advisors LLC37,000$63.3K
Cassaday & Co Wealth Management LLC20,584$35.2K
Keudell/Morrison Wealth Management13,000$22.2K
Qube Research & Technologies Ltd2$3

Not filed for Q3 2024 yet (1)

Institutions that held Fortress Biotech, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FBIO in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.109,957$188.0K